Early stereotactic body radiation therapy improves progression-free survival of first-generation EGFR tyrosine kinase inhibitors in EGFR-mutated lung cancer: an observational cohort study

Hailing Xu, Rongbin Qi, Chao Zhou, Yingying Yu, Ling Lin, Xiaomai Wu, Dongqing Lv · 2024

Read Early stereotactic body radiation therapy improves progression-free survival of first-generation EGFR tyrosine kinase inhibitors in EGFR-mutated lung cancer: an observational cohort study by Hailing Xu, Rongbin Qi, Chao Zhou, Yingying Yu, Ling Lin, Xiaomai Wu, Dongqing Lv (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11536526.txt.

Description

Xu and six co-authors report a study from twenty twenty-four on adding focused radiation to drug care for lung cancer. The patients had late-stage lung cancer with a gene change that lets a targeted drug work. Such drugs often stop working over time. The team asked if early, tightly aimed radiation to the main lung tumor could delay that failure. They compared patients who got the drug alone with patients who got both.

The combined group went longer before the disease grew again, about fifteen and a half months against about nine. Total survival was much the same in both groups. Lung swelling from radiation rose, but cases were mostly mild. The authors say early focused radiation may help hold the drug's effect.

Catalog record

CREATORHailing Xu, Rongbin Qi, Chao Zhou, Yingying Yu, Ling Lin, Xiaomai Wu, Dongqing Lv
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11536526

Browse the full library · About the Tower of Babel